• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

IMPROVE-PD Finder: A Web-Based Platform to Search and Share Peritoneal Dialysis Biobank, Registry, and Clinical Trial Metadata.

作者信息

Damgov Ivan, Bartosova Maria, Marinovic Iva, Istanbuly Obaida, Kieser Meinhard, Lambie Mark, Davies Simon J, Schmitt Claus Peter

机构信息

Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.

Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.

出版信息

Kidney Int Rep. 2023 Jan 7;8(4):912-915. doi: 10.1016/j.ekir.2023.01.003. eCollection 2023 Apr.

DOI:10.1016/j.ekir.2023.01.003
PMID:37069973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10105041/
Abstract
摘要

相似文献

1
IMPROVE-PD Finder: A Web-Based Platform to Search and Share Peritoneal Dialysis Biobank, Registry, and Clinical Trial Metadata.IMPROVE-PD查找器：一个用于搜索和共享腹膜透析生物样本库、注册库及临床试验元数据的基于网络的平台。
Kidney Int Rep. 2023 Jan 7;8(4):912-915. doi: 10.1016/j.ekir.2023.01.003. eCollection 2023 Apr.
2
The RD-Connect Registry & Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers.RD-Connect 注册中心和生物样本库查找器：一个用于在罕见病研究人员之间共享汇总数据和元数据的工具。
Eur J Hum Genet. 2018 May;26(5):631-643. doi: 10.1038/s41431-017-0085-z. Epub 2018 Feb 2.
3
Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol.多中心、实用、整群随机对照试验，比较标准化腹膜透析（PD）培训与常规护理对 PD 相关感染的影响（TEACH-PD 试验）：试验方案。
Trials. 2023 Nov 14;24(1):730. doi: 10.1186/s13063-023-07715-0.
4
Biocompatibility of new peritoneal dialysis solutions: what can we hope to achieve?新型腹膜透析液的生物相容性：我们期望达成什么目标？
Perit Dial Int. 2000;20 Suppl 5:S57-67.
5
Comparison Between Hemodialysis and Peritoneal Dialysis in the Risks for Disease Activity in LN-ESRD Patients: A Systematic Review and Meta-analysis.血液透析与腹膜透析对 LN-ESRD 患者疾病活动风险的比较：系统评价和荟萃分析。
Altern Ther Health Med. 2022 Sep;28(6):144-149.
6
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
7
[Conservative treatment, hemodialysis or peritoneal dialysis for elderly patients: The choice of treatment does not influence the survival].老年患者的保守治疗、血液透析或腹膜透析：治疗方式的选择不影响生存率
Nephrol Ther. 2016 Feb;12(1):32-7. doi: 10.1016/j.nephro.2015.07.473. Epub 2015 Nov 26.
8
Automated peritoneal dialysis versus continuous ambulatory peritoneal dialysis for people with kidney failure.自动化腹膜透析与持续不卧床腹膜透析治疗肾衰竭患者的比较。
Cochrane Database Syst Rev. 2024 Sep 11;9(9):CD006515. doi: 10.1002/14651858.CD006515.pub2.
9
Switch from Hemodialysis to Peritoneal Dialysis: Does the Time Spent on Hemodialysis Impact Outcomes in Peritoneal Dialysis?从血液透析转为腹膜透析：血液透析时间对腹膜透析结局是否有影响？
Am J Nephrol. 2022;53(7):542-551. doi: 10.1159/000524960. Epub 2022 Jun 22.
10
Peritoneal Dialysis Registry With 2013 Survey Report.2013年腹膜透析登记处调查报告
Ther Apher Dial. 2016 Dec;20(6):557-568. doi: 10.1111/1744-9987.12520.

引用本文的文献

1
Integrative Analysis of Drug Co-Prescriptions in Peritoneal Dialysis Reveals Molecular Targets and Novel Strategies for Intervention.腹膜透析中药物联合处方的综合分析揭示了分子靶点和新的干预策略。
J Clin Med. 2025 May 26;14(11):3733. doi: 10.3390/jcm14113733.
2
Health data space nodes for privacy-preserving linkage of medical data to support collaborative secondary analyses.用于医疗数据隐私保护链接以支持协作二次分析的健康数据空间节点。
Front Med (Lausanne). 2024 Apr 10;11:1301660. doi: 10.3389/fmed.2024.1301660. eCollection 2024.

本文引用的文献

1
Lithium preserves peritoneal membrane integrity by suppressing mesothelial cell αB-crystallin.锂通过抑制间皮细胞αB-晶体蛋白来维持腹膜膜完整性。
Sci Transl Med. 2021 Aug 25;13(608). doi: 10.1126/scitranslmed.aaz9705.
2
Glucose Derivative Induced Vasculopathy in Children on Chronic Peritoneal Dialysis.葡萄糖衍生物诱导慢性腹膜透析儿童血管病变。
Circ Res. 2021 Aug 20;129(5):e102-e118. doi: 10.1161/CIRCRESAHA.121.319310. Epub 2021 Jul 8.
3
Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid.丙氨酰-谷氨酰胺恢复传统腹膜透析液破坏后的紧密连接组织。
Biomolecules. 2020 Aug 13;10(8):1178. doi: 10.3390/biom10081178.
4
Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.靶向 Toll 样受体 2 可预防腹膜透析液诱导的纤维化。
Kidney Int. 2018 Aug;94(2):346-362. doi: 10.1016/j.kint.2018.03.014. Epub 2018 May 31.
5
Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy.补体激活与腹膜透析相关性小动脉病。
J Am Soc Nephrol. 2018 Jan;29(1):268-282. doi: 10.1681/ASN.2017040436. Epub 2017 Oct 18.
6
The Current State of Peritoneal Dialysis.腹膜透析的现状
J Am Soc Nephrol. 2016 Nov;27(11):3238-3252. doi: 10.1681/ASN.2016010112. Epub 2016 Jun 23.
7
Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.奈必洛尔，一种β1肾上腺素能阻滞剂，可预防腹膜透析过程中引起的腹膜损伤。
Oncotarget. 2016 May 24;7(21):30133-46. doi: 10.18632/oncotarget.8780.
8
Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT.雷帕霉素通过抑制血管生成、淋巴管生成和内皮-间充质转化来预防I型腹膜膜衰竭。
Biomed Res Int. 2015;2015:989560. doi: 10.1155/2015/989560. Epub 2015 Nov 25.
9
Peritoneal dialysis--current status and future challenges.腹膜透析--现状与未来挑战。
Nat Rev Nephrol. 2013 Jul;9(7):399-408. doi: 10.1038/nrneph.2013.100. Epub 2013 May 21.